CMS Administrator Seema Verma Statement on Drug Industry Price Transparency Announcement
"Under President Trump and Secretary Azar’s leadership to lower prescription drug prices, Americans are seeing results. This year CMS released an overhauled version of our drug spending dashboards, which provided patients with pricing information for thousands more drugs than ever before and, for the first time, listed the prescription drug manufacturers that were responsible for price increases. CMS appreciates the pharmaceutical industry’s action to increase transparency, but additional steps are required to ensure that patients have all of the information they need when they are learning about a medication."